Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

Intermediate Dose Enoxaparin in Hospitalized Patients With Moderate-severe COVID19: A Pilot Phase II Single-arm Study, INHIXACOVID19

NCT04427098 is registered in ClinicalTrials.gov with IRCCS Azienda Ospedaliero-Universitaria di Bologna as lead sponsor.

NCT NCT04427098
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT04427098 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
Intermediate Dose Enoxaparin in Hospitalized Patients With Moderate-severe COVID19: A Pilot Phase II Single-arm Study, INHIXACOVID19
Lead sponsor
IRCCS Azienda Ospedaliero-Universitaria di Bologna
Phase
Phase 2
Overall status
Completed
Start date
May 22, 2020
Completion date
September 29, 2021
Enrollment
301 (actual)
Sites
13

Conditions

As the registry lists them; a condition with its own page is linked.

covid-19